Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ENDRA Life Sciences Inc. NDRA

Set alert

Price alert · NDRA

All alert types
4.80 USD +0.05 +1.05%

At close · Nov 2

4.79 -0.01 -0.21%

After hours · Nov 2, 4:00 PM ET

Bid
4.70 × 2
Ask
4.90 × 2
4.64 Day range 4.89
2.96 52-week range 6.95
YTD
+5.96%
1 year
-8.57%
Open
4.64
Prev close
4.75
Mkt cap
7.20M
Vol
5.78K
Avg vol
31.14K
EPS
-6.26
P/E
0.00
Div yield
0.00%
More statistics
Low
4.64
High
4.89
Forward P/E
-0.02
Beta
0.74
Short ratio
0.05
Inst. own
0.49%
Dividend
0.00
Ex-div date
50-d avg
6.68
200-d avg
291.96
1y target
2,625.00

1M chart

Chart tools
Interval
1m5m15m30m

Signals (7)
NameDateAgo
SMA: BullishNov 2, 202610 hours ago
SMA: BearishOct 30, 20263 days ago
SMA: BullishOct 29, 20264 days ago
SMA: BearishOct 28, 20265 days ago
SMA: BullishOct 26, 20261 week ago
SMA: BearishOct 12, 20263 weeks ago
SMA: BearishOct 8, 20263 weeks ago

Financial health

Altman Z-Score

-19.47 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -0.5×
FY 2016: -9606×FY 2017: -6193×FY 2018: -1207×FY 2019: -1418×FY 2020: -2105×FY 2021: -4427×FY 2022: -1559×FY 2023: -630×FY 2024: -0.6×FY 2025: -0.5×
FY 2016 5y median -630× FY 2025
P/S 0.0×
FY 2016: 51719×FY 2017: 94702×FY 2018: 1915332×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.6×
FY 2016: -29835×FY 2017: 6312×FY 2018: 1893×FY 2019: 4632×FY 2020: 3514×FY 2021: 4594×FY 2022: 1908×FY 2023: 1120×FY 2024: 2.7×FY 2025: 1.6×
FY 2016 5y median 1120× FY 2025
P/FCF -0.7×
FY 2016: -20268×FY 2017: -10064×FY 2018: -1516×FY 2019: -2554×FY 2020: -2328×FY 2021: -4436×FY 2022: -1060×FY 2023: -661×FY 2024: -0.9×FY 2025: -0.7×
FY 2016 5y median -661× FY 2025
EV/EBITDA -0.5×
FY 2016: -15442×FY 2017: -7294×FY 2018: -1313×FY 2019: -2034×FY 2020: -2223×FY 2021: -4500×FY 2022: -1064×FY 2023: -647×FY 2024: -0.4×FY 2025: -0.5×
FY 2016 5y median -647× FY 2025
EV/Sales 0.0×
FY 2016: 51721×FY 2017: 94686×FY 2018: 1914283×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -145.8%
FY 2016: -0.0%FY 2017: -0.0%FY 2018: -0.1%FY 2019: -0.0%FY 2020: -0.0%FY 2021: -0.0%FY 2022: -0.1%FY 2023: -0.2%FY 2024: -105.6%FY 2025: -145.8%
FY 2016 5y median -0.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 54.3%FY 2017: 50.9%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -347.5%FY 2017: -1315.6%FY 2018: -146080.5%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -538.3%FY 2017: -1529.2%FY 2018: -158669.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -310.9%
FY 2016: 310.5%FY 2017: -101.9%FY 2018: -156.8%FY 2019: -279.5%FY 2020: -163.6%FY 2021: -104.1%FY 2022: -182.9%FY 2023: -177.8%FY 2024: -449.5%FY 2025: -310.9%
FY 2016 5y median -182.9% FY 2025
ROIC -178.3%
FY 2016: -3187.7%FY 2017: -87.7%FY 2018: -144.3%FY 2019: -195.9%FY 2020: -144.9%FY 2021: -99.3%FY 2022: -169.8%FY 2023: -173.8%FY 2024: -262.9%FY 2025: -178.3%
FY 2016 5y median -173.8% FY 2025
ROA -182.4%
FY 2016: -565.5%FY 2017: -87.8%FY 2018: -135.6%FY 2019: -185.4%FY 2020: -133.8%FY 2021: -87.2%FY 2022: -142.1%FY 2023: -148.9%FY 2024: -258.5%FY 2025: -182.4%
FY 2016 5y median -148.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -63.4%FY 2017: -31.8%FY 2018: -98.2%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 46.7%
FY 2016: -14.2%FY 2017: -158.2%FY 2018: -95.0%FY 2019: -20.2%FY 2020: -6.1%FY 2021: 0.0%FY 2022: -14.4%FY 2023: 20.0%FY 2024: -2.8%FY 2025: 46.7%
FY 2016 FY 2025
EPS (diluted) 12.9%
FY 2016: -21.8%FY 2017: -93.3%FY 2018: -58.3%FY 2019: 4.6%FY 2020: 69.9%FY 2021: 56.1%FY 2022: -25.0%FY 2023: 13.9%FY 2024: -74.0%FY 2025: 12.9%
FY 2016 FY 2025
Free Cash Flow 29.9%
FY 2016: -34.7%FY 2017: -151.5%FY 2018: -135.8%FY 2019: -10.6%FY 2020: -25.4%FY 2021: -3.2%FY 2022: -16.2%FY 2023: 26.1%FY 2024: 22.6%FY 2025: 29.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 0.1×FY 2017: 6.9×FY 2018: 7.1×FY 2019: 3.2×FY 2020: 8.3×FY 2021: 7.8×FY 2022: 5.0×FY 2023: 3.4×FY 2024: 5.7×FY 2025: 1.3×
FY 2016 5y median 5.0× FY 2025
Quick Ratio 1.3×
FY 2016: 0.1×FY 2017: 6.7×FY 2018: 7.1×FY 2019: 3.1×FY 2020: 7.7×FY 2021: 7.0×FY 2022: 3.5×FY 2023: 3.4×FY 2024: 5.7×FY 2025: 1.3×
FY 2016 5y median 3.5× FY 2025
Debt / Equity 0.2×
FY 2016: -1.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.3×FY 2025: 0.2×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: -0.5×FY 2017: 1.2×FY 2018: 0.7×FY 2019: 0.5×FY 2020: 0.6×FY 2021: 0.8×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.0×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -12.4×FY 2019: -4.6×FY 2020: -49.5×FY 2021: 0.0×FY 2022: -611×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.1%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -31.7%FY 2020: -3.4%FY 2021: -1.1%FY 2022: -0.1%FY 2023: -0.0%FY 2024: -0.0%FY 2025: 0.0%
FY 2016 5y median -0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31